Companion Animal Postoperative Pain Management Therapeutics Market Analysis, Region & Country Revenue Share, & Forecast Till 2032

The global companion animal postoperative pain management therapeutics market reached USD 681.81 million in 2022 and is projected to attain USD 1.20 billion by 2032, with a notable revenue Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The robust growth in market revenue is primarily attributed to various factors, including the increasing adoption of companion animals, a rise in the prevalence of surgical procedures in these animals, and a growing awareness among pet owners about the significance of pain management for animals.

One of the primary drivers of revenue growth in the companion animal postoperative pain management therapeutics market is the escalating global adoption of companion animals. Pets such as dogs, cats, and horses are being adopted at an increasing rate, leading to a substantial rise in the number of surgical procedures conducted on these animals. Consequently, there is a heightened demand for postoperative pain management therapeutics designed for companion animals to ensure their well-being and recovery.

Request a sample report of Companion Animal Postoperative Pain Management Therapeutics Market @ https://www.reportsanddata.com/download-free-sample/6341

Moreover, pet owners are becoming more aware of the importance of Postoperative Pain Management in their pets, which is further driving revenue growth of the market. According to the American Veterinary Medical Association (AVMA), pain management is an essential component of Veterinary Care and is a critical part of the postoperative recovery process in companion animals.

In addition, increasing prevalence of surgical procedures in companion animals is also driving demand for postoperative pain management therapeutics. Surgical procedures such as spaying, neutering, and orthopedic surgeries are common in companion animals and often result in significant postoperative pain. This has led to development of a variety of postoperative pain management therapeutics specifically designed for companion animals.

Strategic Development:

  • On 3 August 2020, Elanco Animal Health Incorporated completed its acquisition of Bayer AG’s animal health business for USD 7.6 billion. The acquisition helped Elanco Animal Health Incorporated to expand its product offerings and strengthen its presence in the global animal health market.
  • On 7 February 2020, Zoetis Inc. acquired Ethos Diagnostic Science, which is a U.S.-based veterinary reference laboratory for USD 490 million. The acquisition helped Zoetis to expand its diagnostic capabilities and strengthen its position in the companion animal postoperative pain management therapeutics market.

Key Players covered in this report are

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Bayer AG
  • Dechra Pharmaceuticals PLC
  • Norbrook Laboratories Limited
  • Ceva Sante Animale S.A.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Aratana Therapeutics Inc.

Product Type Outlook (Revenue, USD Billion; 2019-2032)

  • Non-steroidal Anti-inflammatory Drugs
  • Opioids
  • Local Anesthetics
  • Others

Route of Administration Outlook (Revenue, USD Billion; 2019-2032)

  • Oral
  • Injectable
  • Others

Read the full report @ https://www.reportsanddata.com/report-detail/companion-animal-postoperative-pain-management-therapeutics-market

Based on Region market is segmented into:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

Major Points covered in this report are as below:

  • An analysis of Companion Animal Postoperative Pain Management Therapeutics industry development trends and marketing channels, as well as an assessment of the feasibility of new investment projects, is presented in the study.
  • In addition to providing key statistics on the industry, the report provides valuable guidance and direction for companies and individuals interested in this market through tables and figures.
  • In addition to developing policies and plans, this report analyzes manufacturing processes and cost structures. It also provides information about import/export demand, costs, prices, revenues, and gross margins.
  • This report provides information on the market status of Companion Animal Postoperative Pain Management Therapeutics manufacturers and provides valuable insight into the market for companies and individuals.

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/6341

We can also provide the customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central & South America, Brazil, Argentina, Rest of South America, Middle East & Africa, Saudi Arabia, Turkey, Rest of Middle East & Africa

Browse More Reports:

Aerogel Market @ https://www.reportsanddata.com/report-detail/aerogel-market

Architectural Coating Market @ https://www.reportsanddata.com/report-detail/architectural-coatings-market

Anionic Surfactants Market @ https://www.reportsanddata.com/report-detail/anionic-surfactants-market

Cardiomyopathy Medication Market @ https://www.reportsanddata.com/report-detail/cardiomyopathy-medication-market

Radiotherapy Motion Management Market @ https://www.reportsanddata.com/report-detail/radiotherapy-motion-management-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Recommended For You

About the Author: ashinde

subscriber

Leave a Reply

Your email address will not be published. Required fields are marked *